These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9234190)

  • 1. Exfoliative cheilitis (EC) in AIDS: association with Candida infection.
    Reichart PA; Weigel D; Schmidt-Westhausen A; Pohle HD
    J Oral Pathol Med; 1997 Jul; 26(6):290-3. PubMed ID: 9234190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cheilitis as a variation of Candida-associated lesions.
    Terai H; Shimahara M
    Oral Dis; 2006 May; 12(3):349-52. PubMed ID: 16700747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
    Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
    AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic analysis of oral Candida carriage, distribution, and antifungal susceptibility in HIV-infected patients during the first year of highly active antiretroviral therapy in Guangxi, China.
    Jiang L; Yong X; Li R; Peng Y; Liu W; Qin Q; Zhang L; Liu Z; Liang H; Tao R
    J Oral Pathol Med; 2014 Oct; 43(9):696-703. PubMed ID: 24931443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
    Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
    Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
    Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
    J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis.
    Villanueva A; Gotuzzo E; Arathoon EG; Noriega LM; Kartsonis NA; Lupinacci RJ; Smietana JM; DiNubile MJ; Sable CA
    Am J Med; 2002 Sep; 113(4):294-9. PubMed ID: 12361815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection.
    Tumbarello M; Caldarola G; Tacconelli E; Morace G; Posteraro B; Cauda R; Ortona L
    J Antimicrob Chemother; 1996 Oct; 38(4):691-9. PubMed ID: 8937963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.
    Vazquez JA; Skiest DJ; Nieto L; Northland R; Sanne I; Gogate J; Greaves W; Isaacs R
    Clin Infect Dis; 2006 Apr; 42(8):1179-86. PubMed ID: 16575739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candida-Associated Cheilitis.
    Ohta K; Yoshimura H
    Am J Med Sci; 2020 Dec; 360(6):e17-e18. PubMed ID: 32684336
    [No Abstract]   [Full Text] [Related]  

  • 11. Fluconazole-resistant Candida species in the oral flora of fluconazole-exposed HIV-positive patients.
    Hunter KD; Gibson J; Lockhart P; Pithie A; Bagg J
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 May; 85(5):558-64. PubMed ID: 9619674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral Candida albicans isolates with reduced susceptibility to fluconazole in Swedish HIV-infected patients.
    Chryssanthou E; Torssander J; Petrini B
    Scand J Infect Dis; 1995; 27(4):391-5. PubMed ID: 8658076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.
    Saag MS; Fessel WJ; Kaufman CA; Merrill KW; Ward DJ; Moskovitz BL; Thomas C; Oleka N; Guarnieri JA; Lee J; Brenner-Gati L; Klausner M
    AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1413-7. PubMed ID: 10555103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40.
    Goldman M; Cloud GA; Wade KD; Reboli AC; Fichtenbaum CJ; Hafner R; Sobel JD; Powderly WG; Patterson TF; Wheat LJ; Stein DK; Dismukes WE; Filler SG; ;
    Clin Infect Dis; 2005 Nov; 41(10):1473-80. PubMed ID: 16231260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oropharyngeal candidiasis resistant to fluconazole in patients infected by HIV].
    Drobacheff C; Manteaux A; Millon L; Reboux G; Barale T; Laurent R
    Ann Dermatol Venereol; 1996; 123(2):85-9. PubMed ID: 8761757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of itraconazole in treating AIDS-associated infections due to Candida krusei.
    Coppola S; Angarano G; Montagna MT; Congedo P; Monno L; Bellisario A; Pastore G
    Eur J Epidemiol; 1995 Apr; 11(2):243-4. PubMed ID: 7672085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of sargramostim (rh-GM-CSF) as adjunctive treatment of fluconazole-refractory oropharyngeal candidiasis in patients with AIDS: a pilot study.
    Vazquez JA; Hidalgo JA; De Bono S
    HIV Clin Trials; 2000; 1(3):23-9. PubMed ID: 11590502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis.
    Barchiesi F; Arzeni D; Del Prete MS; Sinicco A; Falconi Di Francesco L; Pasticci MB; Lamura L; Nuzzo MM; Burzacchini F; Coppola S; Chiodo F; Scalise G
    J Antimicrob Chemother; 1998 May; 41(5):541-8. PubMed ID: 9630407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Factors related to oral candidiasis in HIV children and adolescents, species characterization and antifungal susceptibility].
    Castillo-Martínez NA; Mouriño-Pérez RR; Cornejo-Bravo JM; Gaitán-Cepeda LA
    Rev Chilena Infectol; 2018 Aug; 35(4):377-385. PubMed ID: 30534924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of vaginal Candida species recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis: the emergence of Candida glabrata? Terry Beirn Community Programs for Clinical Research in AIDS (CPCRA).
    Vazquez JA; Sobel JD; Peng G; Steele-Moore L; Schuman P; Holloway W; Neaton JD
    Clin Infect Dis; 1999 May; 28(5):1025-31. PubMed ID: 10452629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.